News EU probes Aspen price gouging allegations Aspen pulled drugs from some countries that rejected price hikes, says EU.
News GSK sells anaesthetics portfolio to Aspen Companies also end collaboration in sub-Saharan Africa.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.